Immunotherapy Research Journal is an open access, peer-reviewed, the multidisciplinary journal. Journal ambition is to publish the most ground-breaking and cutting-edge research from all over the world. The Journal publishes all types of articles such as research, reviews, cases, communications, etc., in the field of Vaccine informatics,Reproductive immunology research,Translational immunology,Molecular immunology research,Immunovirology,Immunotoxicology,Stem cell immunotherapy,Immunotherapeutic products,Cellular immunotherapy,Antibody immunotherapy,Immune enhancement therapy,Cancer immunotherapy etc. All published articles are accepted after peer review process by highly qualified, expert reviewers to meet the objectives of the standard scientific publication.
A statistical representation of global users for Immunotherapy Research Journal (Source: Google Analytics)
The archived content of the journal represents the track of progress made in this field over the past years. The information gathered by the journal functions as resource of refined knowledge for academicians, scientists, physicians, clinical and medical professionals. The volume of information contained on the journal web-site is contributed by authors from different regions of the world. Due to these reasons readers hailing from diverse professional backgrounds and regions are interested in the journal content.
iMedPub was established in the year 2005 and since then has been actively publishing peer-reviewed articles in biomedical and clinical science; material science; mathematics and engineering topics. iMedPub follows standard editorial and production policies with Internationally acclaimed publication practices.
Due to wide variation in the journal portfolio, the publisher site is accessed by various communities of diverse scientific disciplines from reputed research organizations, academic institution and Government bodies. More than 2,822,814 users have accessed the publisher website with more than 7,758,847 page views. These stats reveal that the journal is also immensely popular among scientific societies and organizations. Consequently, the editorial board profiles, authors and their affiliations are also gaining higher visibility.
The number of web sessions, the publisher received was 3,595,693 at the rate of 2.16 new sessions. This implied that new users and visitors are flocking to the publisher bases. A number of users are also revisiting the publisher pages indicating their continued interest in the journal. The fast and efficient publishing standard set by iMedPub was found to be very impressive by the reader base and is being well appreciated; as evident from the web metrics. The metric displayed belong only to our journals and if the associated links are also taken into consideration the number would be significantly much higher.